Back To Schedule
Monday, June 24 • 11:00am - 12:00pm
#113: Artificial Intelligence in Drug Discovery and Development: Emerging Technologies and Applications

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

Component Type: Forum
Level: Intermediate
CE: ACPE 1.00 Knowledge UAN: 0286-0000-19-527-L04-P; CME 1.00; IACET 1.00; RN 1.00

A discussion of advances in artificial intelligence and related technologies in computer, information and data science, specifically as they apply to challenges and emerging application areas within pre-clinical drug discovery and early drug development.

Learning Objectives

Describe translatable experiences and practices concerning impactful applications of artificial intelligence.


Scott Spangler, MA


Panelist: Activity Metabolomics and ArtificiaI Predictions
Erica Majumder, PhD

Challenges and Opportunities in Near-Term Quantum Computation
Yudong Cao, PhD, MS

Craig Lipset, MPH

avatar for Craig Lipset

Craig Lipset

Former Head of Clinical Innovation, Pfizer
Craig Lipset has led at the intersection of patient engagement, personal health data, and accelerating clinical research. He created and led Clinical Innovation at Pfizer, developing and scaling “first in industry” approaches to improving patient experience and innovative data... Read More →
avatar for Erica Majumber

Erica Majumber

Associate Director and Senior Safety Science Leader IIDO, Scripps Research
Dr. Majumder is a researcher with Dr. Gary Siuzdak in the Scripps Center for Metabolomics and Mass Spectrometry. Erica specializes in anaerobic metabolism and the activity of sulfur-containing metabolites. Recently, she has been spearheading their lab's new efforts using AI-based... Read More →

Yudong Cao

Co-founder and CTO, Zapata Computing
Yudong Cao is co-founder and CTO of Zapata Computing, a quantum software startup based in Cambridge, MA. His PhD thesis in Computer Science received 2016 Chorafas Award in Computer Science and Informatics. From 2016 to 2018 he worked as a postdoctoral researcher at Harvard University... Read More →

Scott Spangler

Distinguished Engineer, Chief Data Scientist for Life Sciences, IBM Watson
Scott Spangler is Chief Data Scientist, Distinguished Engineer, and Master Inventor in the Watson Health Life Sciences Group at the IBM Almaden Research Center. He has been doing knowledge base and data mining research for the past 25 years. Since coming to IBM in 1996, Scott has... Read More →

Monday June 24, 2019 11:00am - 12:00pm PDT
Room 2 San Diego Convention Center 111 W Harbor Drive, San Diego, CA 92101 USA
  06: PreClin Dev-EarlyPhaseCR, Forum
  • Featured Topics Artificial Intelligence,Innovative Trial Design,What's Next,Student Programming
  • Credit Type ACPE, CME, IACET, RN
  • Tags Forum